Skip to content

Medical-device intelligence

Abbott: selected FDA company records

Connect selected Abbott source names with their classification, clearance, and recall histories.

Included source names

Membership is based on Abbott Laboratories, 2025 Form 10-K, Exhibit 21 ↗, as of Jan 31, 2026. Mapping checked Nov 19, 2026. This is a selected research group, not a complete corporate family or a statement of current ownership.

  • Abbott Laboratories
  • Abbott Diabetes Care Inc.
  • Abbott Point of Care Inc.
  • Abbott Cardiovascular Systems Inc.
  • Abbott Molecular Inc.
  • Abbott Vascular Inc.

Matching FDA profiles

Names without a matching profile contribute no records. Punctuation and case are normalized; legal-name variants and private customer aliases are not merged automatically. Each underlying record is counted once.

Record activity in this scope

978 clearance records and 344 recall records in the covered releases, across 5 source company names and 318 product codes. Dated history runs from Sep 16, 1976 to Sep 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202505
December 202500
January 202600
February 202600
March 202600
April 202613
May 202600
June 202620
July 202600
August 202600
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

1,322 matching records
Device / recordCompany in FDA recordSourceSource date
GLUK981185 · CFRAbbott Laboratories510(k)May 7, 1998FDA decision date
URIC ACIDK981189 · CDOAbbott Laboratories510(k)May 7, 1998FDA decision date
MGK981192 · JGJAbbott Laboratories510(k)May 1, 1998FDA decision date
CREATINE KINASE (CK)K981218 · CGSAbbott Laboratories510(k)May 1, 1998FDA decision date
IRONK981241 · JIYAbbott Laboratories510(k)May 1, 1998FDA decision date
TBILK981336 · CIGAbbott Laboratories510(k)May 1, 1998FDA decision date
ABBOTT AXSYM 3RD GENERATION TSH ASSAYK981060 · JLWAbbott Laboratories510(k)Apr 29, 1998FDA decision date
ABBOTT CELL-DYN 3000 SERIES HEMATOLOGY SYSTEMSK980614 · GKZAbbott Laboratories510(k)Apr 24, 1998FDA decision date
DIRECT BILIRUBIN (DBIL)K981222 · CIGAbbott Laboratories510(k)Apr 24, 1998FDA decision date
ASPARTATE AMINOTRANSFERASE ACTIVATED ( AST ACTIVATED)K981221 · CITAbbott Laboratories510(k)Apr 23, 1998FDA decision date
ASPARTATE AMINOTRANSFERASE (AST)K981225 · CITAbbott Laboratories510(k)Apr 23, 1998FDA decision date
AEROSET SYSTEMK980367 · CGZAbbott Laboratories510(k)Apr 1, 1998FDA decision date
ABBOTT GEMSTAR IV INFUSION PUMPK974778 · FRNAbbott Laboratories510(k)Mar 17, 1998FDA decision date
ABBOTT TESTPACK PLUS STREP A WITH ON BOARD CONTROLS (OBC) IIK971522 · GTZAbbott Laboratories510(k)Mar 3, 1998FDA decision date
ABBOTT ALCYON(TM) 300 (WITHOUT ISE MODULE) AND 300I (WITH ISE MODULE) ANALYZERK974779 · JJEAbbott Laboratories510(k)Feb 13, 1998FDA decision date
ABBOTT AXSYM SYSTEMK974651 · JJEAbbott Laboratories510(k)Feb 12, 1998FDA decision date
ABBOTT AXSYM TROPONIN-IK974103 · MMIAbbott Laboratories510(k)Nov 25, 1997FDA decision date
IMX CA 15-3K964407 · MOIAbbott Laboratories510(k)Nov 10, 1997FDA decision date
FLEXIFLO LOW-PROFILE BALLOON GASTROSTOMY TUBEK962554 · KNTAbbott Laboratories510(k)Nov 7, 1997FDA decision date
AXSYM CA 125K964020 · LTKAbbott Laboratories510(k)Nov 4, 1997FDA decision date
ABBOTT CELL-DYN 3200 SYSTEMK972354 · GKZAbbott Laboratories510(k)Sep 16, 1997FDA decision date
AXSYM CA 15-3K963926 · MOIAbbott Laboratories510(k)Sep 15, 1997FDA decision date
ABBOTT CELL-DYN 4000 IMMATURE RETICULOCYTE FRACTION (IRF)K971152 · GKZAbbott Laboratories510(k)Aug 12, 1997FDA decision date
ABBOTT AXSYM FOLATEK972232 · CGNAbbott Laboratories510(k)Jun 24, 1997FDA decision date
ABBOTT CMV TOTAL ANTIBODY EIA (MODIFICATION)K954301 · LFZAbbott Laboratories510(k)Mar 24, 1997FDA decision date
Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗